Stoke Therapeutics (STOK) Preferred Shares (2018)

Stoke Therapeutics' Preferred Shares history runs 1 years deep, the most recent figure standing at $28.9 million for Q4 2018.

• In Q4 2018, Preferred Shares changed N/A year-over-year to $28.9 million; the TTM figure through Dec 2018 stood at $28.9 million (changed N/A YoY), while the FY2018 annual figure was $28.9 million, changed N/A from the prior year.
• Preferred Shares for Q4 2018 stood at $28.9 million.
• The five-year high for Preferred Shares was $28.9 million in Q4 2018, with the low at $28.9 million in Q4 2018.